Show simple item record

dc.contributor.authorDALMAU, Josep
dc.contributor.authorTuzun, Erdem
dc.date.accessioned2021-03-03T15:13:05Z
dc.date.available2021-03-03T15:13:05Z
dc.date.issued2007
dc.identifier.citationTuzun E., DALMAU J., "Limbic encephalitis and variants: Classification, diagnosis and treatment", NEUROLOGIST, cilt.13, sa.5, ss.261-271, 2007
dc.identifier.issn1074-7931
dc.identifier.otherav_3dd8cd1f-ee60-4175-8e56-b23adbfb3120
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/45432
dc.identifier.urihttps://doi.org/10.1097/nrl.0b013e31813e34a5
dc.description.abstractBackground and Objective: Recent studies suggest that a substantial number of patients with autoimmune limbic encephalitis may improve if properly diagnosed and treated. This is due, in part, to the increasing recognition of disorders that associate with antibodies to neuronal cell membrane antigens. This review focuses in these disorders, trained in a clinically useful immunologic classification of limbic encephalitis.
dc.language.isoeng
dc.subjectNöroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleLimbic encephalitis and variants: Classification, diagnosis and treatment
dc.typeMakale
dc.relation.journalNEUROLOGIST
dc.contributor.department, ,
dc.identifier.volume13
dc.identifier.issue5
dc.identifier.startpage261
dc.identifier.endpage271
dc.contributor.firstauthorID1762


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record